secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K/A
Filed at:   2021-12-28T23:59:59+00:00
Accession:  0001104659-21-153907
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte amends 8-K to correct Dr. Lawson departure date from Dec 31 2022 to Dec 31 2021
--------------------------------------------------------------------------------

- Original 8-K reported departure of Dr. Jeffrey Lawson as Chief Surgical Officer and board resignation.
- Amendment corrects separation date from December 31, 2022 to December 31, 2021 due to scrivener error.
- No other changes to the original disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465921153907/0001104659-21-153907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465921153907/tm2136448d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-153907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer